Xavier Matias-Guiu Guia
Grau: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grups
Publicacions
-
Goebel, EA; Vidal, A; Matias-Guiu, X; Blake Gilks C
The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future
VIRCHOWS ARCHIV 472 885-896. .
-
Capdevila, J; Mayor, R; Mancuso, FM; Iglesias, C; Caratu, G; Matos, I; Zafon, C; Hernando, J; Petit, A; Nuciforo, P; Cameselle-Teijeiro, JM; Alvarez, C; Recio, JA; Tabernero, J; Matias-Guiu, X; Vivancos, A; Seoane, J
Early evolutionary divergence between papillary and anaplastic thyroid cancers
ANNALS OF ONCOLOGY 29 1454-1460. .
-
Alsina-Sanchis, E; Garcia-Ibanez, Y; Figueiredo, AM; Riera-Domingo, C; Figueras, A; Matias-Guiu, X; Casanovas, O; Botella, LM; Pujana, MA; Riera-Mestre, A; Graupera, M; Viñals F
ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 38 1216-1229. .
-
Bosse, T; Nout, RA; McAlpine, JN; McConechy, MK; Britton, H; Hussein, YR; Gonzalez, C; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Vidal, A; Matias-Guiu, X; Abu-Rustum, NR; Levine, DA; Gilks, CB; Soslow, RA
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 42 561-568. .
-
Garrido, P; Aldaz, A; Vera, R; Calleja, MA; de Alava, E; Martin, M; Matias-Guiu, X; Palacios, J
Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH
CLINICAL & TRANSLATIONAL ONCOLOGY 20 443-447. .
-
Zhu, C; Farre, G; Zanga, D; Lloveras, J; Michelena, A; Ferrio, JP; Voltas, J; Slafer, G; Savin, R; Albajes, R; Eizaguirre, M; Lopez, C; Cantero-Martinez, C; Diaz-Gomez, J; Nogareda, C; Moreno, JA; Angulo, E; Estany, J; Pena, RN; Tor, M; Portero-Otin, M; Eritja, N; Arjo, G; Serrano, JCE; Matias-Guiu, X; Twyman, RM; Sandmann, G; Capell, T; Christou, P
High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition
PHYTOCHEMISTRY REVIEWS 17 195-209. .
-
Cuppens, T; Moisse, M; Depreeuw, J; Annibali, D; Colas, E; Gil-Moreno, A; Huvila, J; Carpen, O; Zikan, M; Matias-Guiu, X; Moerman, P; Croce, S; Lambrechts, D; Amant, F
Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways
INTERNATIONAL JOURNAL OF CANCER 142 1230-1243. .
-
Segura, Sheila E.; Bi, Rui; Kumar, Rahul; Vidal, August; Gatius, Sonia; Abu-Rustum, Nadeem; Matias-Guiu, Xavier; DeLair, Deborah; Weigelt, Britta
Hotspot TERT Promoter Mutations in Adult-Type Granulosa Cell Tumors of the Ovary as Potential Drivers of Progression
Modern Pathology 31 451-451. .
-
Leon, Alicia; McAlpine, Jessica N.; Nout, Remi; McConechy, Melissa K.; Ganesan, Raji; Matias-Guiu, Xavier; Oliva, Esther; Harrison, Beth T.; Soslow, Robert; Church, David; Gilks, C. Blake; Bosse, Tjalling
Clinicopathological Characterization of Endometrial Carcinomas with More Than One Molecular Classifying Feature
Modern Pathology 31 434-434. .
-
Segura, SE; Bi, R; Kumar, R; Vidal, A; Gatius, S; Abu-Rustum, N; Matias-Guiu, X; DeLair, D; Weigelt, B
Hotspot TERT Promoter Mutations in Adult-Type Granulosa Cell Tumors of the Ovary as Potential Drivers of Progression
LABORATORY INVESTIGATION 98 451-451. .
-
Oaknin, A; Guarch, R; Barretina, P; Hardisson, D; Gonzalez-Martin, A; Matias-Guiu, X; Perez-Fidalgo, A; Vieites, B; Romero, I; Palacios, J
Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
CLINICAL & TRANSLATIONAL ONCOLOGY 20 274-285. .
-
Van Der Putten L.J.M.; Visser N.C.M.; van de Vijver, K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Garcia, A; Mancebo, G; Alameda, F; Trovik, J; Kopperud, RK; Huvila, J; Schrauwen, S; Koskas, M; Walker, F; Weinberger, V; Minar, L; Jandakova, E; Snijders M.P.L.M.; van den Berg-van Erp, S; Matias-Guiu, X; Salvesen, HB; Werner H.M.J.; Amant, F; Massuger L.F.A.G.; Pijnenborg J.M.A.
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28 514-523. .
Projectes
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment